Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882478 · ClinicalTrials.gov registry record
Cryotherapy -BEATS-RF Ablation Trial
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 15
- Enrollment target
NCT01882478: Completed study, sponsored by Mayo Clinic.
NCT01882478 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01882478 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cryotherapy is effective in the treatment of persistent high grade dysplasia (HGD) or early esophageal adenocarcinoma (IMCA) in patients who have not responded to radiofrequency ablation (RFA).
Primary Outcome
To assess efficacy of achieving elimination of dysplasia in patients with RFA-refractory BE with HGD or IMCA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-06 |
| Est. Completion | 2021-06 |
What the finished NCT01882478 record still lists
NCT01882478 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01882478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01882478 about?
NCT01882478 is a clinical study titled "Cryotherapy -BEATS-RF Ablation Trial". The purpose of this study is to determine whether cryotherapy is effective in the treatment of persistent high grade dysplasia (HGD) or early esophageal adenocarcinoma (IMCA) in patients who have not responded to radiofrequency ablation (RFA).
What is the current status of trial NCT01882478?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2013-06. Estimated completion is 2021-06.
Who is sponsoring clinical trial NCT01882478?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia